Loading clinical trials...
Loading clinical trials...
A Phase II Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer
Conditions
Interventions
Capecitabine
Oxaliplatin
Locations
6
Switzerland
Basel, Switzerland
Chur, Switzerland
Lucerne, Switzerland
Sankt Gallen, Switzerland
Zurich, Switzerland
Zurich, Switzerland
Start Date
March 1, 2005
Primary Completion Date
August 1, 2006
Completion Date
November 1, 2006
Last Updated
January 11, 2017
NCT04929028
NCT06696768
NCT04704661
NCT05489211
NCT04674267
NCT04657068
Lead Sponsor
Hoffmann-La Roche
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions